| Literature DB >> 10431158 |
M L Lupher1, N Rao, M J Eck, H Band.
Abstract
The Cbl protooncoprotein has recently emerged as a component of tyrosine kinase-mediated signal transduction in a variety of cell types. Here, we discuss evidence that supports a role for Cbl as a novel negative regulator of immune receptor signaling, and present models for its mode of function.Entities:
Mesh：
Substances：
Year: 1999 PMID： 10431158 DOI： 10.1016/s0167-5699(99)01484-x
Source DB: PubMed Journal: Immunol Today ISSN： 0167-5699